Smitha Kota

808 total citations
18 papers, 630 citations indexed

About

Smitha Kota is a scholar working on Hepatology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Smitha Kota has authored 18 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hepatology, 6 papers in Molecular Biology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Smitha Kota's work include Hepatitis C virus research (7 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Cancer Mechanisms and Therapy (2 papers). Smitha Kota is often cited by papers focused on Hepatitis C virus research (7 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Cancer Mechanisms and Therapy (2 papers). Smitha Kota collaborates with scholars based in United States, France and United Kingdom. Smitha Kota's co-authors include Scott Troutman, Joseph L. Kissil, Keith Brew, A. Donny Strosberg, Virginia Takahashi, Silvia Licciulli, John K. Snyder, Shuo Wei, Feng Ni and Mohammad Fallahi and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Smitha Kota

18 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Smitha Kota United States	14	275	142	132	100	73	18	630
Casie Reed United States	14	632 2.3×	268 1.9×	156 1.2×	71 0.7×	59 0.8×	19	974
Takemitsu Nagahata Japan	15	515 1.9×	162 1.1×	86 0.7×	229 2.3×	101 1.4×	24	906
Fonda M. Newcomb United States	8	289 1.1×	202 1.4×	30 0.2×	82 0.8×	26 0.4×	12	601
Feng Peng China	15	273 1.0×	225 1.6×	208 1.6×	146 1.5×	89 1.2×	33	767
Natalie Grinshtein Canada	16	359 1.3×	284 2.0×	95 0.7×	91 0.9×	8 0.1×	23	850
Weicheng Wu China	19	892 3.2×	203 1.4×	301 2.3×	98 1.0×	33 0.5×	41	1.3k
Jason Borawski United States	9	459 1.7×	59 0.4×	86 0.7×	65 0.7×	35 0.5×	11	648
Koichiro Ono Japan	6	385 1.4×	104 0.7×	213 1.6×	77 0.8×	16 0.2×	9	739
Marla Weetall United States	18	795 2.9×	164 1.2×	97 0.7×	53 0.5×	31 0.4×	70	1.2k

Countries citing papers authored by Smitha Kota

Since Specialization

Citations

This map shows the geographic impact of Smitha Kota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Smitha Kota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Smitha Kota more than expected).

Fields of papers citing papers by Smitha Kota

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Smitha Kota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Smitha Kota. The network helps show where Smitha Kota may publish in the future.

Co-authorship network of co-authors of Smitha Kota

This figure shows the co-authorship network connecting the top 25 collaborators of Smitha Kota. A scholar is included among the top collaborators of Smitha Kota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Smitha Kota. Smitha Kota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Kota, Smitha, Shurong Hou, William Guerrant, et al.. (2018). A novel three-dimensional high-throughput screening approach identifies inducers of a mutant KRAS selective lethal phenotype. Oncogene. 37(32). 4372–4384. 16 indexed citations

Guerrant, William, Smitha Kota, Scott Troutman, et al.. (2016). YAP Mediates Tumorigenesis in Neurofibromatosis Type 2 by Promoting Cell Survival and Proliferation through a COX-2–EGFR Signaling Axis. Cancer Research. 76(12). 3507–3519. 48 indexed citations

Troutman, Scott, Susana Moleirinho, Smitha Kota, et al.. (2016). Crizotinib inhibits NF2-associated schwannoma through inhibition of focal adhesion kinase 1. Oncotarget. 7(34). 54515–54525. 24 indexed citations

Vera, Ian Mitchelle S. de, Angela F. Brady, Audrey S. Richard, et al.. (2016). Ebselen, a Small-Molecule Capsid Inhibitor of HIV-1 Replication. Antimicrobial Agents and Chemotherapy. 60(4). 2195–2208. 89 indexed citations

Kota, Smitha, Franck Madoux, Peter Chase, et al.. (2014). ML322, A Small Molecule Inhibitor of Dimerization of the Core Protein of Hepatitis C Virus (HCV). 1 indexed citations

Licciulli, Silvia, Jacqueline L. Avila, Linda Hanlon, et al.. (2013). Notch1 Is Required for Kras-Induced Lung Adenocarcinoma and Controls Tumor Cell Survival via p53. Cancer Research. 73(19). 5974–5984. 93 indexed citations

Licciulli, Silvia, Jasna Maksimoska, Chun Zhou, et al.. (2013). FRAX597, a Small Molecule Inhibitor of the p21-activated Kinases, Inhibits Tumorigenesis of Neurofibromatosis Type 2 (NF2)-associated Schwannomas. Journal of Biological Chemistry. 288(40). 29105–29114. 108 indexed citations

Kazantzis, Melissa, Virginia Takahashi, Smitha Kota, et al.. (2012). PAZ6 Cells Constitute a Representative Model for Human Brown Pre-Adipocytes. Frontiers in Endocrinology. 3. 13–13. 13 indexed citations

Kota, Smitha, Virginia Takahashi, Feng Ni, John K. Snyder, & A. Donny Strosberg. (2012). Direct Binding of a Hepatitis C Virus Inhibitor to the Viral Capsid Protein. PLoS ONE. 7(2). e32207–e32207. 17 indexed citations

10.

Ni, Feng, Smitha Kota, Virginia Takahashi, A. Donny Strosberg, & John K. Snyder. (2011). Potent inhibitors of hepatitis C core dimerization as new leads for anti-hepatitis C agents. Bioorganic & Medicinal Chemistry Letters. 21(8). 2198–2202. 17 indexed citations

11.

Snyder, John K., Scott C. Benson, Lily Lee, et al.. (2011). Truncated Aspidosperma Alkaloid-Like Scaffolds: Unique Structures for the Discovery of New, Bioactive Compounds. Heterocycles. 84(1). 135–135. 3 indexed citations

12.

Wei, Wanguo, Cuifang Cai, Smitha Kota, et al.. (2010). ChemInform Abstract: New Small Molecule Inhibitors of Hepatitis C Virus.. ChemInform. 41(16). 3 indexed citations

13.

Strosberg, A. Donny, Smitha Kota, Virginia Takahashi, John K. Snyder, & Guillaume Mousseau. (2010). Core as a Novel Viral Target for Hepatitis C Drugs. Viruses. 2(8). 1734–1751. 27 indexed citations

14.

Kota, Smitha, Louis Scampavia, Timothy Spicer, et al.. (2009). A Time-Resolved Fluorescence–Resonance Energy Transfer Assay for Identifying Inhibitors of Hepatitis C Virus Core Dimerization. Assay and Drug Development Technologies. 8(1). 96–105. 21 indexed citations

15.

Wei, Wanguo, Cuifang Cai, Smitha Kota, et al.. (2009). New small molecule inhibitors of hepatitis C virus. Bioorganic & Medicinal Chemistry Letters. 19(24). 6926–6930. 16 indexed citations

16.

Wei, Shuo, et al.. (2007). Constraining specificity in the N‐domain of tissue inhibitor of metalloproteinases‐1; gelatinase‐selective inhibitors. Protein Science. 16(9). 1905–1913. 56 indexed citations

17.

Wei, Shuo, Masahide Kashiwagi, Smitha Kota, et al.. (2005). Reactive Site Mutations in Tissue Inhibitor of Metalloproteinase-3 Disrupt Inhibition of Matrix Metalloproteinases but Not Tumor Necrosis Factor-α-converting Enzyme. Journal of Biological Chemistry. 280(38). 32877–32882. 45 indexed citations

18.

Azzarolo, Ana Maria, et al.. (2004). Presence of tear lipocalin and other major proteins in lacrimal fluid of rabbits. Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology. 138(2). 111–117. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact